These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21905270)

  • 1. A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis.
    Stalvey MS; Anbar RD; Konstan MW; Jacobs JR; Bakker B; Lippe B; Geller DE
    Pediatr Pulmonol; 2012 Mar; 47(3):252-63. PubMed ID: 21905270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V; Carter B; Putman M
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD008901. PubMed ID: 30557452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V; Haagensen AL; Carter B; Fedorowicz Z; Houston BW
    Cochrane Database Syst Rev; 2015 May; (5):CD008901. PubMed ID: 25991406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial.
    Hardin DS; Adams-Huet B; Brown D; Chatfield B; Dyson M; Ferkol T; Howenstine M; Prestidge C; Royce F; Rice J; Seilheimer DK; Steelman J; Shepherds R
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4925-9. PubMed ID: 17018651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V; Haagensen AL; Carter B; Fedorowicz Z; Houston BW
    Cochrane Database Syst Rev; 2013 Jun; 6(6):CD008901. PubMed ID: 23737090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
    Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human growth hormone in the treatment of patients with cystic fibrosis.
    Phung OJ; Coleman CI; Baker EL; Scholle JM; Girotto JE; Makanji SS; Chen WT; Talati R; Kluger J; White CM
    Pediatrics; 2010 Nov; 126(5):e1211-26. PubMed ID: 20921071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
    Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I; Demirel F; Tepe D; Kara O; Koc N
    Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency. The Genentech Cooperative Study Group.
    Fine RN; Brown DF; Kuntze J; Wooster P; Kohaut EE
    J Pediatr; 1996 Dec; 129(6):883-91. PubMed ID: 8969731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
    Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
    Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients.
    Huseman CA; Colombo JL; Brooks MA; Smay JR; Greger NG; Sammut PH; Bier DM
    Pediatr Pulmonol; 1996 Aug; 22(2):90-5. PubMed ID: 8875581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis.
    Hendriks JJ; Kester AD; Donckerwolcke R; Forget PP; Wouters EF
    Pediatr Pulmonol; 2001 Jan; 31(1):59-66. PubMed ID: 11180676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone on exercise tolerance in children with cystic fibrosis.
    Hütler M; Schnabel D; Staab D; Tacke A; Wahn U; Böning D; Beneke R
    Med Sci Sports Exerc; 2002 Apr; 34(4):567-72. PubMed ID: 11932561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome.
    Polgreen LE; Thomas W; Orchard PJ; Whitley CB; Miller BS
    Mol Genet Metab; 2014 Feb; 111(2):101-6. PubMed ID: 24368158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study.
    Labarta JI; de Arriba A; Ferrer M; Loranca M; Martos JM; Rodríguez A; Samaniego ML; Sánchez-Cenizo L
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):923-932. PubMed ID: 32623373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study.
    Simon D; Prieur AM; Quartier P; Charles Ruiz J; Czernichow P
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2567-73. PubMed ID: 17488793
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.